Praetorian Bio is proud to announce the formation of its Advisory Board, bringing together a world-class group of scientific, clinical, and industry leaders to guide the company’s mission to transform oral health through vaccines.
The Advisory Board includes:
- Jeannine Brady, PhD – Professor, University of Florida College of Dentistry; expert in antigenic characterization of oral pathogens, protective immunity, and Streptococcus mutans pathogenesis.
- Daniel Smith, PhD – Emeritus Senior Staff, Forsyth; former Associate Clinical Professor, Harvard Medical School/Harvard School of Dental Medicine; expert in caries antigen identification and clinical trial design.
- Martin Taubman, DDS, PhD – Former Chairman of Immunology, Forsyth; Emeritus Professor, Harvard Medical School/Harvard School of Dental Medicine; pioneer in caries and periodontal vaccine development and IgA mucosal antibody responses.
- Esteban Plata, PhD – Former Vice President for Western Europe and Canada at AbbVie, with over 15 years of senior leadership roles across global markets including Asia-Pacific and Europe. He holds a Ph.D. in Biotechnology from the National Research Council in Spain and brings deep expertise in pharmaceutical innovation, market access, and cross-regional operations.
“We are honored to welcome such an accomplished group of advisors to Praetorian Bio,” said Dr. Francisco Leon, Chairman of the Board. “Their expertise and insights — from fundamental immunology to global pharmaceutical leadership — will be instrumental as we move from preclinical proof-of-concept to first-in-human studies” added Dr. Dinja Oosterhoff, Chief Scientific Officer to Praetorian Bio. . Together with the esteemed SAB members Praetorian is laying the foundation for a new era of prevention in oral health.”
The Advisory Board strengthens Praetorian Bio’s foundation in scientific excellence and global collaboration, reinforcing its commitment to making preventive oral vaccines accessible worldwide.
